← Alle mensen

EP

Elena Poddubskaya

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monothera...

European journal of cancer (Oxford, England : 1990) · 9 september 2025

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Gevorderd or Metastatic Non-Small Cell Lung Cancer: Th...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2025

Lazertinib versus gefitinib als eerstelijns bij EGFR-gemuteerd NSCLC: LASER301 fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 september 2023

Tislelizumab versus docetaxel bij eerder behandeld NSCLC: RATIONALE-303 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-01

Ensartinib versus crizotinib bij ALK-positief NSCLC: eXalt3 fase III

JAMA oncology · 1 november 2021

Nivolumab versus docetaxel bij eerder behandeld NSCLC: tweejaarsuitkomsten CheckMate 017/057

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 december 2017